Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SDGR · against 404 other Healthcare companies of similar size
Ranked #308 of 405 · scores higher than 24% of peers · safety percentile 25
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)38 peers with a safety percentile of 20–29, including SDGR · Click a bar to see the companies
Mainly because of its beta, which is weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | SDGR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 384 reported | 0.33× | 0.22× | 38% | 33% | |
| BetaLower is better · 381 reported | 1.69 | 0.58 | 9% | 33% | |
| Current ratioHigher is better · 390 reported | 2.71× | 2.90× | 47% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 1.1B USD | 100 | ||
| 5 | 3.6B USD | 99 | ||
| 304 | 3.1B EUR (≈$3.4B) | 26 | 47 | |
| 305 | 1.7B USD | 25 | 44 | |
| 306 | 2.4B CHF (≈$2.7B) | 25 | 59 | |
| 307 | 1.3B CHF (≈$1.5B) | 25 | 48 | |
| 308 | 2.0B USD | 25 | 26 | |
| 309 | 73.5B TRY (≈$2.2B) | 24 | 68 | |
| 310 | 3.4B EUR (≈$3.7B) | 24 | 64 | |
| 311 | 3.0B USD | 24 | 11 | |
| 312 | 1.3B USD | 24 | 48 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score